Published in Obstet Gynecol on December 01, 2011
Optical coherence tomography for assessment of microbicide safety in a small animal model. J Biomed Opt (2013) 0.83
Image-based noninvasive evaluation of colorectal mucosal injury in sheep after topical application of microbicides. Sex Transm Dis (2013) 0.81
Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography. Am J Obstet Gynecol (2013) 0.81
Automated segmentation algorithm for detection of changes in vaginal epithelial morphology using optical coherence tomography. J Biomed Opt (2012) 0.77
Topical injury evaluation of the murine colorectal mucosa using confocal endomicrosopy: a valuable method for assessing mucosal injuries associated with risk of pathogen transmission. J Microsc (2016) 0.75
Colposcopic imaging using visible-light optical coherence tomography. J Biomed Opt (2017) 0.75
Visualization of synthetic mesh utilizing optical coherence tomography. Int Urogynecol J (2013) 0.75
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00
Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med (1996) 5.63
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses (2005) 3.89
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One (2008) 3.45
The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials (2005) 2.98
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86
A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS (2008) 2.43
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group. AIDS (2000) 1.82
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception (1999) 1.50
Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol (2000) 1.44
High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides. Sex Transm Dis (2009) 1.38
Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology (2004) 1.38
Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS (2004) 1.35
Fourteen-day safety and acceptability study of the universal placebo gel. Contraception (2006) 1.27
Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: potential for assessment of microbicide safety. Sex Transm Dis (2008) 1.13
Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix. Int J Gynecol Cancer (2006) 1.11
Optical coherence tomography as an adjunct to flexible bronchoscopy in the diagnosis of lung cancer: a pilot study. Chest (2010) 1.06
Perceptions of reimbursement for clinical trial participation. J Empir Res Hum Res Ethics (2011) 0.98
Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials. Contraception (2007) 0.92
Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations. Am J Obstet Gynecol (2008) 0.89
A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observers. Contraception (2004) 0.86
Baseline colposcopic findings in women entering studies on female vaginal products. Contraception (2008) 0.84
Colposcopically obtained images of vulvar, vaginal, and cervical epithelium for assessment of safety of intravaginal agents among normal adolescent females: comparison with in vivo exam and interobserver agreement. J Low Genit Tract Dis (2003) 0.79
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses (2005) 3.89
High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system. Nano Lett (2007) 3.01
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86
Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health (2008) 2.74
Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) (2009) 2.54
Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol Imaging Biol (2004) 2.44
Religion/spirituality and adolescent health outcomes: a review. J Adolesc Health (2006) 2.37
Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol (2008) 2.36
Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine (2006) 2.32
APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol (2006) 2.27
Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS (2003) 2.15
Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. Arch Dermatol (2011) 2.13
Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics (2009) 2.10
Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis (2006) 2.01
Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health (2005) 2.00
Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet Gynecol (2008) 1.98
Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health (2010) 1.84
Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis (2004) 1.79
Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev (2009) 1.74
Complications associated with surveying medical student depression: the importance of anonymity. Acad Psychiatry (2003) 1.71
Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob Agents Chemother (2008) 1.68
Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results. J Womens Health (Larchmt) (2005) 1.68
Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet (2002) 1.67
Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills. Am J Obstet Gynecol (2008) 1.67
Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr (2007) 1.66
Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax. Infect Immun (2006) 1.59
Outcomes of morbidly obese patients requiring mechanical ventilation for acute respiratory failure. Crit Care Med (2007) 1.59
Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Lett (2009) 1.57
In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis (2011) 1.56
Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health (2010) 1.51
Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis (2003) 1.48
Use of complementary and alternative medicine for the treatment of genital herpes. Herpes (2005) 1.48
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest (2002) 1.46
Vaccination: an opportunity to enhance early adolescent preventative services. J Adolesc Health (2006) 1.43
Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One (2013) 1.43
Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila) (2009) 1.43
Racial differences in body fat distribution among reproductive-aged women. Metabolism (2009) 1.42
Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media. Pediatrics (2006) 1.42
Systemic cytokine response profiles associated with respiratory virus-induced acute otitis media. Pediatr Infect Dis J (2009) 1.42
Stability and predictors of health-related quality of life of inner-city girls. J Dev Behav Pediatr (2003) 1.41
A self-sampling method to obtain large volumes of undiluted cervicovaginal secretions. Sex Transm Dis (2003) 1.40
High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides. Sex Transm Dis (2009) 1.38
Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics (2002) 1.38
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob Agents Chemother (2011) 1.38
Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Infect Immun (2007) 1.37
Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods (2004) 1.37
Mental health issues in adolescents and young adults with type 1 diabetes: prevalence and impact on glycemic control. Clin Pediatr (Phila) (2012) 1.32
Adolescent immunizations: a position paper of the Society for Adolescent Medicine. J Adolesc Health (2006) 1.28
Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis (2003) 1.28
Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J (2005) 1.27
Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health (2007) 1.26
Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infect Dis (2005) 1.26
The impact of adolescent spirituality on depressive symptoms and health risk behaviors. J Adolesc Health (2005) 1.26
Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol (2007) 1.25
Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis (2002) 1.25
Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine (2009) 1.25
Optoacoustic technique for noninvasive monitoring of blood oxygenation: a feasibility study. Appl Opt (2002) 1.24
Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal lactobacilli. Infect Immun (2002) 1.24
Correlates of anxiety symptoms during pregnancy and association with perinatal outcomes: a meta-analysis. Am J Obstet Gynecol (2007) 1.23
Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men. J Acquir Immune Defic Syndr (2003) 1.23
Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers. Clin Pediatr (Phila) (2012) 1.21
Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med (2012) 1.21
Precision of measurement of tissue optical properties with optical coherence tomography. Appl Opt (2003) 1.20
Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis (2010) 1.19
Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J Virol (2002) 1.19
Noninvasive blood glucose monitoring with optical coherence tomography: a pilot study in human subjects. Diabetes Care (2002) 1.18
Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol (2002) 1.18
Inverted colloidal crystals as three-dimensional cell scaffolds. Langmuir (2004) 1.18
Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus. Obstet Gynecol (2004) 1.18
Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis (2005) 1.17
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine. Clin Infect Dis (2005) 1.16
Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents. Sex Transm Dis (2002) 1.15
Religious/Spiritual coping in adolescents with sickle cell disease: a pilot study. J Pediatr Hematol Oncol (2009) 1.15
Pelvic Organ Support Study (POSST) and bowel symptoms: straining at stool is associated with perineal and anterior vaginal descent in a general gynecologic population. Am J Obstet Gynecol (2005) 1.15
Reproductive correlates of depressive symptoms among low-income minority women. Obstet Gynecol (2003) 1.14
Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: potential for assessment of microbicide safety. Sex Transm Dis (2008) 1.13
Optoacoustic imaging of the prostate: development toward image-guided biopsy. J Biomed Opt (2010) 1.12
Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use. J Womens Health (Larchmt) (2006) 1.10
Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings. AIDS (2012) 1.10
Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics (2014) 1.09
Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol Cell Biol (2012) 1.09
Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. J Infect Dis (2005) 1.08
Predictors of using a microbicide-like product among adolescent girls. J Adolesc Health (2007) 1.08
Rape acknowledgment and postassault experiences: how acknowledgment status relates to disclosure, coping, worldview, and reactions received from others. Violence Vict (2006) 1.08
Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Dig Dis Sci (2009) 1.08
A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr (2010) 1.07
Nanoscale engineering of a cellular interface with semiconductor nanoparticle films for photoelectric stimulation of neurons. Nano Lett (2007) 1.07
Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health (2007) 1.07
Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women. J Clin Virol (2009) 1.05
Parental acceptance of adolescent vaccines within school-based health centres. Herpes (2005) 1.04
VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection. Int J Nanomedicine (2007) 1.04